TheraRadar
Data updated: May 26, 2026

ACYCLOVIR SODIUM

Infectious Disease Approved 1997-04-22

ACYCLOVIR SODIUM is indicated for the treatment of Herpes Simplex Infections; Herpes Genitalis; Herpes Simplex Encephalitis; Neonatal Herpes Simplex Virus Infection; Varicella-Zoster.

Source: FDA Label • SLATE RUN PHARMA
16
Indications
--
Phase 3 Trials
29
Years on Market

ACYCLOVIR SODIUM Approval History

1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
82 FDA actions from 1997 to 2025
Feb 2025 SUPPL
Label · Labeling
Jun 2024 ORIGINAL
Update
Mar 2024 SUPPL
Label · Labeling

What ACYCLOVIR SODIUM Treats

5 indications

ACYCLOVIR SODIUM is approved for 5 conditions since its original approval in 1997. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Herpes Simplex Infections
  • Herpes Genitalis
  • Herpes Simplex Encephalitis
  • Neonatal Herpes Simplex Virus Infection
  • Varicella-Zoster
Source: FDA Label

ACYCLOVIR SODIUM Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT00855309 results posted IRB00007690 P30CA012197, CCCWFU-98608 Ph 3 completed Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ACYCLOVIR SODIUM FDA Label Details

Indications & Usage

ACYCLOVIR SODIUM is indicated for the treatment of Herpes Simplex Infections; Herpes Genitalis; Herpes Simplex Encephalitis; Neonatal Herpes Simplex Virus Infection; Varicella-Zoster.

Looking for the branded version?

ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE

Full clinical data, patents, trials, and competitive landscape for acyclovir sodium.

See ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.